and multivariate comparative analyisis was performed, in order to define which variables were related to the negativity or positivity of HLAB27. Results: Data of 1235 AS pacients were analysed. Of them 1029 (83.3%) were HLAB27 positive and 206 (17.7%) HLAB27 negative. 924 (74.8%) were men. AS patients with HLAB27+ presented significantly more familiar history of spondyloarhritis (p=0.002), were younger (p=0.012) and had earlier disease onset and disease diagnosis (p<0.001), with a longer disease duration (p=0.037) and a trend to a higher percentage of uveitis compared to those with HLAB27-. On the other hand, AS patients with HLAB27-also presented significantly more peripheral arthritis (p=0.0022), dactylitis (p=0.001) and extraarticular manifestations (psoriasis, palmoplantar pustulosis, inflammatory bowel disease (IBD) and balanitis (p<0.001)) compared with those of HLAB27+. AS patients with HLAB27-also presented higher scores of BASDAI and BASFI (p=0.047 and p=0.005 respectively). The study didn't show differences between both groups of patients regarding sex distribution, axial manifestations, enthesitis nor radiological damage (assessed by BASRI). In the multivariate analysis, the family history of spondyloarthritis (OR 2.10, IC95% 1.27-3.49, p=0.004), the age at diagnosis (OR 0.97, IC95% 0.96-0.98, p<0.001), the presence of dactylitis (OR 0.16, IC95% 0.05-0.56, p=0.004), extraarticular manifestation specially IBD (OR 0.22, p<0.001) and peripheral arthritis (OR 0.53, p=0.016) were the variables independently associated with the presence of HLAB27.
Background: Spondyloarthritis (SpA) is a group of chronic inflammatory rheumatism and it is known to be one of the leading causes of disability. Objectives: This study aimed to investigate the quality of life and the psychological disorders (depression, anxiety and insomnia) in patients with SpA. Methods: A total of 60 patients were included with the diagnosis of SpA meeting the Amor and New York modified criteria, in a prospective study. In a questionnaire, the characteristics of the disease and sociodemographic patient were collected. Also psychiatric assessment was done using the insomnia severity index score (ISI) and the Hospital Anxiety and Depression scale (HAD). In addition, patients answered to the Ankylosing Spondylitis Quality of Life (ASQoL) questionnaire and the SF-12. Results: The sex-ratio (men/women) was 3.28 (46/14), the average age was 37.95 years (18-70). The average duration of disease progression was 11.5 years (1-30). The mean value of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) was 5.11 and the Bath Ankylosing Spondylitis Functional Index (BASFI) was 5.22. Uveitis was reported in 11.7% of patients, osteoporosis in 35%, enthesitis in 36.7% and coxitis in 36.7%. 78.3% of patients received NSIAD and 30% were treated with biotheraby. On the psychological level, 25% of patients had an anxiety, 20% had depression. According to the ISI, 35% of patients had sub threshold insomnia, 20% had moderate insomnia and 10% had severe insomnia. The mean value of the ASQoL was 9 (0-16). The mean value of the physical health was 37. 13 (19.34-60.41 ) and for the mental health was 41.65 (14.9-60.35) . A significant positive correlation was found between the disease activity and the ASQoL (p=0.000), the physical health (p=0.000) and the mental health (p=0.002). Also, we found a significant positive correlation between the BASDAI and depression (p=0.01) and insomnia (p=0.001). Conclusions: SpA is a chronic inflammatory disease that contributes to significant physical disability and decreased quality of life in a significant number of patients. The treatment of those patients must consider the improvement of quality of life, as part of a global approach. Background: Screening latent tuberculosis (TB) and other opportunistic infections in patients with spondyloarthropathies (SpA) with biologic or immunosuppression therapy is important in highly endemic population (1). Objectives: To assess the prevalence of latent and active TB, hepatitis B, hepatitis C, HIV and Syphilis in a colombian cohort with SpA, as well as evaluate differences between treatments. Methods: A cross-sectional study was conducted in 621 patients with SpAs, in whom TB, hepatitis B, hepatitis C, HIV and syphilis screening was analyzed based on type of diagnosis. Differences among immunomodulatory therapies were assessed. Statistical association was examined by means of Chi-square tests, Mann-Whitney test, and logistic regression analyses. Results: The prevalence of latent and active TB in this cohort were 63,1%, and 2,9%, respectively. Significant differences were found in proportions of latent and active TB among types of SpAs, indicating a positive association with AS. A high Ankylosing spondylitis (AS), psoriatic arthritis (PsA), undifferentiated spondyloarthritis (Und SpA), tuberculin skin test (TST).
